CircRNA-GLP003

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameCircRNA-GLP003
Drug Alias NamecircRNA-GLP003
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Circular RNA
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTherorna Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherorna Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A